One of the best known communications executives in corporate America, Susman worked at Pfizer for nearly two decades after ...

NYC mayoral frontrunner Zohran Mamdani is expected to talk with NYC business leaders in a series of closed-door meetings next ...

European Commission President Ursula von der Leyen has pushed back against a no-confidence motion in the European Parliament, ...

Leerink Partners called the announcement a ‘positive’ given the delayed timeframe and the uncertainty that the administration ...

Pfizer has promoted Albert Bourla, seen as a likely successor to incumbent CEO Ian Read, to the newly-created role of chief operating officer. The move could help Read focus on long-term strategy ...

The motion of censure against the von der Leyen Commission, formally submitted on July 3, 2025, and scheduled for vote on July 10, 2025, presents three principal categories of alleged violations with ...

The four Fianna Fáil MEPs will not vote against the EU Commission president, Ursula von Der Leyen, in a censure motion at the ...

Tomorrow will be turbulent day in European Parliament. MEPs will vote on whether Ursula von der Leyen should continue to lead ...

(Reuters) -Pfizer and other drug companies have met with the Trump administration to discuss lowering U.S. drug prices but no commitments have been made, Chief Executive Albert Bourla said on Monday.

Von der Leyen’s ongoing political ambiguity has become a strategic liability at a time when Europe’s allies need clarity.

(Reuters) -Pfizer and other drug companies have met with the Trump administration to discuss lowering U.S. drug prices but no commitments have been made, Chief Executive Albert Bourla said on Monday.